Detection of a streptomycin-resistant Mycobacterium bovis strain through antitubercular drug susceptibility testing of Tunisian Mycobacterium tuberculosis complex isolates from cattle
Open Access
- 29 September 2018
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 14 (1) , 296
Abstract
A rising isolation trend of drug-resistant M. bovis from human clinical cases is documented in the literature. Here we assessed Mycobacterium tuberculosis complex isolates from cattle for drug susceptibility by the gold standard agar proportion method and a simplified resazurin microtitre assay (d-REMA). A total of 38 M. tuberculosis complex strains, including M. bovis (n = 36) and M. caprae (n = 2) isolates, from cattle in Tunisia were tested against isoniazid, rifampin, streptomycin, ethambutol, kanamycin and pyrazinamide. M. caprae isolates were found to be susceptible to all test drugs. All M. bovis strains were resistant to pyrazinamide, as expected. In addition, one M. bovis isolate showed high-level resistance to streptomycin (MIC > 500.0 μg/ml). Concordant results with the two methods were found. The most common target genes associated with streptomycin resistance, namely the rrs, rpsL and gidB genes, were DNA sequenced. A non-synonymous mutation at codon 43 (K43R) was found in the rpsL gene. To the best of our knowledge, this is the first report describing the isolation of a streptomycin-resistant M. bovis isolate from animal origin. Antitubercular drug susceptibility testing of M. bovis isolates from animals should be performed in settings where bTB is endemic in order to estimate the magnitude of the risk of drug-resistant tuberculosis transmission to humans.Keywords
This publication has 51 references indexed in Scilit:
- Human bovine tuberculosis – remains in the differentialJournal of Medical Microbiology, 2010
- Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of BarcelonaJournal of Antimicrobial Chemotherapy, 2010
- Importance of identifyingMycobacterium bovisas a causative agent of human tuberculosis: Fig. 1—European Respiratory Journal, 2010
- Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assaysJournal of Medical Microbiology, 2008
- Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methodsClinical Microbiology and Infection, 2007
- Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assayJournal of Antimicrobial Chemotherapy, 2007
- Resazurin Microtiter Assay Plate Testing of Mycobacterium tuberculosis Susceptibilities to Second-Line Drugs: Rapid, Simple, and Inexpensive MethodAntimicrobial Agents and Chemotherapy, 2003
- Molecular Basis of Rifampin and Isoniazid Resistance in Mycobacterium bovis Strains Isolated in Sardinia, ItalyAntimicrobial Agents and Chemotherapy, 2001
- High Rate of Tuberculosis Reinfection during a Nosocomial Outbreak of Multidrug-Resistant Tuberculosis Caused by Mycobacterium bovis Strain BClinical Infectious Diseases, 2001
- Zoonotic Tuberculosis due to Mycobacterium bovis in Developing CountriesEmerging Infectious Diseases, 1998